PsychoGenics Introduces eCube, an AI-Driven Platform for Drug Discovery in Neuropsychiatric Disorders

PsychoGenics, a prominent player in AI-enabled phenotypic drug discovery and preclinical CRO services, has recently unveiled eCube, an innovative pharmaco-electroencephalography …

Continue ›››

Some Drugs That Improve Price Competition Fall Through The Cracks Of FDA User Fees

Americans are increasingly concerned about rising drug prices. FDA user fees affect drug pricing competition, which is often overlooked. FDA …

Continue ›››

ConcertAI Unveils Next-Generation Clinical Trial Optimization Platform, CTO 2.0

ConcertAI, an AI Software-as-a-Service (SaaS) and Real-World Evidence (RWE) solutions provider for the life sciences and healthcare sectors, recently announced …

Continue ›››

Introducing “Lab-on-a-Molecule” Drug Discovery Approach via DNA Nanoswitches

The challenge faced by current compound screening approaches often lies in their limitations, either in throughput or their capacity to …

Continue ›››

Introducing PathExplore, a Game-Changing AI Tool for In-Depth Tumor Microenvironment Exploration

As we continue to make progress in oncology therapeutics, researchers are constantly seeking ways to improve patient outcomes by understanding …

Continue ›››

The Emergence of Diffusion Generative Models in Accelerating AI Drug Discovery

Recently, diffusion generative models, such as DALL-E 2 and Midjourney, have attracted considerable interest for their ability to create captivating …

Continue ›››

Advancements in Lipid Nanoparticles for Targeted Gene Therapy in the Lungs

Researchers from MIT and the University of Massachusetts Medical School have developed a new type of lipid nanoparticle designed to …

Continue ›››

Top 10 Companies Shaping the Brain-Computer Interface Landscape: Invasive vs Non-Invasive BCI Technology

The brain-computer interface (BCI) technology domain is constantly progressing as researchers and companies collaborate to devise inventive solutions that connect …

Continue ›››

AI-Powered Peptide Discovery from Plant Sources Leads to a Breakthrough In Muscle Recovery

Nuritas, an innovator in AI-based peptide discovery from natural sources, has announced the results of a second clinical trial on …

Continue ›››

AbSci and Other AI-Powered Biotechs Lead the Way in Antibody Discovery

The monoclonal antibodies (mAbs) market has seen impressive growth in recent years, with the top-selling drugs increasingly being mAbs. The …

Continue ›››

QSimulate Launches Quantum Fingerprinting Product to Improve AI Drug Discovery

The field of drug discovery has witnessed a massive transformation in recent years, thanks to the integration of artificial intelligence …

Continue ›››

Gandeeva Therapeutics and Moderna Join Forces to Explore AI-Enabled Cryo-EM Technology

Gandeeva Therapeutics, a precision medicine company specializing in designing and developing novel therapeutics guided by cryogenic electron microscopy (cryo-EM) and …

Continue ›››